HCAT vs HSTM
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
HCAT
HSTM
Investment Advisor Scores
HSTM
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HCAT | HSTM | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 10 | 33.7838 | HCAT |
| PEG Ratio | 0 | 2.8196 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -12.7% | 12.5% | HSTM |
| Earnings Growth | 0.0% | 28.4% | HSTM |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 56.9/100 | 42.8/100 | HCAT |
| Profit Margin | -90.6% | 6.6% | HSTM |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | HCAT |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HCAT
DistributionPrice near a flattening SMA50 (slope -7.8%) with fading momentum, RSI 48
HSTM
MarkupPrice above SMA50, rising 50-day trend (5.0% over 20 days), RSI 70
Fundamentals Snapshot
| Metric | HCAT | HSTM |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 232.0 | 37.9 |
| Trailing P/E | — | 46.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.1% |
| Gross Margin | 0.5% | 0.7% |
| Operating Margin | -0.1% | 0.1% |
| EPS | -3.69 | 0.72 |
| Dividend Yield | — | 0.00% |